로딩 중…
StockDiggingStockDigging

Osang Healthcare Co.,Ltd

036220· KOSDAQ
₩6,350-3.64%
2026-06-19

Price Chart

Osang Healthcare Co.,Ltd-71.96%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap90.86B KRW
Revenue119.38B KRW
Net Income-3.60B KRW
Total Assets341.78B KRW
Net Assets281.66B KRW
Employees343
Value
P/B0.32x
P/S0.76x
FCF Yield-10.87%
Profitability
ROE-1.28%
ROA-1.05%
Op. Margin-9.76%
Revenue Growth-28.80%
Earnings Growth-191.37%
Financial Health
Debt Ratio121.34%
Total Debt46.95B KRW
FCF-9.88B KRW
Cash17.46B KRW
Current Ratio2.59x
Dividend
Div. Yield3.04%
Div. Growth-60.00%
Performance
1Y Return-71.96%
1M Return-14.30%
From 52W High-73.38%
1Y MDD-73.32%
Trading
Volume40,091 shares
Foreign Own.1.94%
Per Share
EPS-305 KRW
BPS20,463 KRW

Company Info

CEO 강철훈, 유병열(각자대표이사)
Employees 343
Founded 1996
HQ 경기도 안양시, KR

Established in 1996, Osang Healthcare develops, produces, and sells biochemical, immunoassay, and molecular diagnostic products in the in-vitro diagnostics field, and was listed on KOSDAQ in 2024. With the new consolidation of OSANG COSMETIC LTDA, a Brazilian cosmetic distribution company, in 2025, the company now holds three subsidiaries. Its product portfolio includes self-blood glucose meters and POCT HbA1c meters for biochemical diagnostics; SelexOn and COVID-19 self-test kits for immunoassay diagnostics; and PCR-based Genefinder products for molecular diagnostics. Osang Healthcare is headquartered in Anyang-si, Gyeonggi-do.